NASDAQ : BYSI
BeyondSpring Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.5167 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 21.25M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 26.47M |
| Enterprise Value | 20.11M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 41.12M |
| Shares Outstanding | 41.12M |
| Shares Change (YoY) | +1.23% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 13.06% |
| Owned by Institutions (%) | 6.75% |
| Float | 32.69M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.70 |
| Quick Ratio | 0.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.86% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -2,021.55% |
| Weighted Average Cost of Capital (WACC) | 3.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$151,932 |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 340,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -64.82% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 54.30 |
| Average Volume (20 Days) | 60,544 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.35M |
| Short Previous Month | 2.44M |
| Short % of Shares Out | 6.90% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.56 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.35M |
| Pretax Income | -8.01M |
| Net Income | -6.69M |
| EBITDA | -8.39M |
| EBIT | -8.35M |
| Earnings Per Share (EPS) | -$0.16 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 6.53M |
| Total Debt | 171,000 |
| Net Cash | 6.36M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | -36.03M |
| Book Value Per Share | -0.86 |
| Working Capital | -4.29M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -16.75M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | -37,000 |
| Net Borrowing | -4.22M |
| Free Cash Flow | -16.75M |
| FCF Per Share | -$0.41 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -25.44% |
| FCF Yield | -63.26% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |